SEC Comment Letter 0000000000-23-000074 to Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786) (HOTH)
Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786)
Date: Jan. 4, 2023 · CIK: 0001711786 · Accession: 0000000000-23-000074
AI Filing Summary & Sentiment
File numbers found in text: 001-38803
Letter
United States securities and exchange commission logo January 4, 2023 David Briones Chief Financial Officer Hoth Therapeutics, Inc. 1 Rockefeller Plaza, Suite 1039 New York, NY 10020 Re:Hoth Therapeutics, Inc. Form 10-K for the Fiscal Year Ended December 31, 2021 Filed March 30, 2022 File No. 001-38803 Dear David Briones: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Haley Springer
Show Raw Text
United States securities and exchange commission logo
January 4, 2023
David Briones
Chief Financial Officer
Hoth Therapeutics, Inc.
1 Rockefeller Plaza, Suite 1039
New York, NY 10020
Re:Hoth Therapeutics, Inc.
Form 10-K for the Fiscal Year Ended December 31, 2021
Filed March 30, 2022
File No. 001-38803
Dear David Briones:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Haley Springer